Blood News and Research

RSS

Allegra V-15R benchtop centrifuge launched by Beckman Coulter Life Sciences during diamond year celebration

Celebrating a 75-year legacy in centrifugation, Beckman Coulter Life Sciences launches its most versatile 3-liter benchtop centrifuge yet – the Allegra V-15R refrigerated centrifuge.

From Beckman Coulter Life Sciences - Flow Cytometry 17 Feb 2022

Novel blood biomarkers can potentially predict melanoma patients' response to immunotherapy

Melanoma, a type of skin cancer, is often curable when detected and treated in its early stages. However, the disease can rapidly spread to other organs in the body and become deadly. According to the American Cancer Society, more than 7,600 people die of the disease each year in the United States.

17 Feb 2022

Exposure to endocrine disrupting mixtures during pregnancy impacts children's brain development

By linking human population studies with experiments in cell and animal models, researchers have provided evidence that complex mixtures of endocrine disrupting chemicals impact children's brain development and language acquisition.

17 Feb 2022

Only half of the people with cardiovascular disease risk receive lifestyle support from GPs, study shows

A new 10-year analysis of people in England newly diagnosed with high blood pressure, high cholesterol or obesity shows only half receive lifestyle support from their GPs.

17 Feb 2022

Intermediate size nanoparticles may be effective at stopping internal bleeding

Traumatic injuries are the leading cause of death in the U.S. among people 45 and under, and such injuries account for more than 3 million deaths per year worldwide.

17 Feb 2022

Dual access veno-arterial approach increases mortality rate for babies in respiratory failure put on ECMO

The current trend of using two cannulas to place most newborns in respiratory failure on life-sustaining ECMO, one in the right internal jugular vein and a second in the right common carotid artery, rather than a single cannula in the right internal jugular, increases mortality rates for these babies, investigators report.

17 Feb 2022

New mutation may define a high-risk subtype of pediatric acute myeloid leukemia

A new mutation was identified in 9 percent of relapsed cases of pediatric acute myeloid leukemia (AML) that may define a new subtype of the disease.

17 Feb 2022

MRI screenings may reduce breast-cancer mortality in women with 3 pathogenic gene variants

Annual MRI screenings starting at ages 30 to 35 may reduce breast-cancer mortality by more than 50% among women who carry certain genetic changes in three genes, according to a comparative modeling analysis to be published Feb. 17, 2022, in JAMA Oncology.

17 Feb 2022

Study describes trajectories of insomnia symptoms from childhood through young adulthood

Children with insomnia symptoms are likely to persist with them as young adults and are significantly more likely to develop an insomnia disorder in early adulthood compared to children who do not have difficulty sleeping, according to new research led by scientists at Penn State College of Medicine.

17 Feb 2022

New high-risk subtype of relapsed pediatric AML revealed

When acute myeloid leukemia (AML) relapses, it is more difficult to treat and outcomes are dismal. Scientists at St. Jude Children's Research Hospital have discovered a mutation in pediatric AML that physicians can use to identify high-risk patients and better guide treatment.

17 Feb 2022

Study reveals mechanisms associated with severe blood clotting in COVID-19 patients

After studying blood samples from 244 patients hospitalized for COVID-19, a group of researchers, including those who work at the National Institutes of Health, identified “rogue antibodies” that correlate with severe illness and may help explain mechanisms associated with severe blood clotting.

17 Feb 2022

Optical genome mapping holds potential to become an important component of leukemia diagnostics

Optical genome mapping involves the extraction of very long DNA molecules, for example routinely collected blood samples or bone marrow material from patients.

17 Feb 2022

Combating leukemia cells by disrupting their energy maintenance mechanism

Acute myeloid leukemia, which affects blood and bone marrow cells, is a particularly dangerous form of cancer. More than half of patients under the age of 60 die.

17 Feb 2022

Study explores humoral and cellular immunity conferred by second and third COVID-19 BNT162b2 vaccination in elderly

Researchers recently assessed SARS-CoV-2-specific humoral and cellular immune responses induced by the second and third doses of the BNT162b2 COVID-19 messenger ribonucleic acid-based vaccine in the elderly.

17 Feb 2022

COVID-19 vaccine-induced immunity in heart and kidney solid organ transplant recipients

The present study entailed assessments of both infected and uninfected SOTRs against the D614G-CoV2 baseline virus and eight other variants.

17 Feb 2022

Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer

Joint study will assess clinical value of comprehensive genomic profiling (CGP) on cancer therapy options in patients with advanced disease

From Illumina, Inc. 17 Feb 2022

Blood News and Research

Allegra V-15R benchtop centrifuge launched by Beckman Coulter Life Sciences during diamond year celebration

Novel blood biomarkers can potentially predict melanoma patients' response to immunotherapy

Exposure to endocrine disrupting mixtures during pregnancy impacts children's brain development

Only half of the people with cardiovascular disease risk receive lifestyle support from GPs, study shows

Intermediate size nanoparticles may be effective at stopping internal bleeding

Dual access veno-arterial approach increases mortality rate for babies in respiratory failure put on ECMO

New mutation may define a high-risk subtype of pediatric acute myeloid leukemia

MRI screenings may reduce breast-cancer mortality in women with 3 pathogenic gene variants

Study describes trajectories of insomnia symptoms from childhood through young adulthood

New high-risk subtype of relapsed pediatric AML revealed

Study reveals mechanisms associated with severe blood clotting in COVID-19 patients

Optical genome mapping holds potential to become an important component of leukemia diagnostics

Combating leukemia cells by disrupting their energy maintenance mechanism

Study explores humoral and cellular immunity conferred by second and third COVID-19 BNT162b2 vaccination in elderly

COVID-19 vaccine-induced immunity in heart and kidney solid organ transplant recipients

Illumina partners with centers across France to advance a precision medicine approach for patients with late-stage cancer

mRNA COVID-19 vaccine shown to induce afucosylated antibodies in individuals without prior SARS-CoV-2 exposure

Frequency and function of SARS-CoV-2-specific T cells in individuals with pulmonary PASC

Memory B cell repertoire in a longitudinal cohort of individuals receiving 3 COVID-19 mRNA vaccine doses

Smartphone-based COVID-19 detection system

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News